Literature DB >> 22764248

Dopamine, corticostriatal connectivity, and intertemporal choice.

Andrew S Kayser1, Daicia C Allen, Ana Navarro-Cebrian, Jennifer M Mitchell, Howard L Fields.   

Abstract

Value-based decisions optimize behavioral outcomes. Because delayed rewards are discounted, an increased tendency to choose smaller, immediate rewards can lead to suboptimal choice. Steep discounting of delayed rewards (impulsivity) characterizes subjects with frontal lobe damage and behavioral disorders including substance abuse. Correspondingly, animal studies and indirect evidence in humans suggest that lower dopamine in the frontal cortex contributes to steeper discounting by impairing corticostriatal function. To test this hypothesis directly, we performed a randomized, double-blind, counterbalanced, placebo-controlled study in which we administered the brain penetrant catechol-O-methyltransferase inhibitor tolcapone or placebo to healthy subjects performing a delay discounting task. Tolcapone significantly increased choice of delayed monetary rewards, and this tolcapone-induced increase covaried with increased BOLD activity in the left ventral putamen and anterior insula. Tolcapone also changed corticostriatal connectivity: specifically, by inducing a decrease in the coherence between ventral putamen and pregenual cingulate cortex. These results indicate that raising cortical dopamine levels attenuates impulsive choice by changing corticostriatal function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22764248      PMCID: PMC6622221          DOI: 10.1523/JNEUROSCI.1180-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  51 in total

1.  Neuroeconomic dissociation of semantic dementia and behavioural variant frontotemporal dementia.

Authors:  Winston Chiong; Kristie A Wood; Alexander J Beagle; Ming Hsu; Andrew S Kayser; Bruce L Miller; Joel H Kramer
Journal:  Brain       Date:  2015-12-14       Impact factor: 13.501

2.  Catechol-O-methyltransferase genotype modulates opioid release in decision circuitry.

Authors:  Jennifer M Mitchell; James P O'Neil; William J Jagust; Howard L Fields
Journal:  Clin Transl Sci       Date:  2013-06-13       Impact factor: 4.689

3.  Cortical dopamine release during a behavioral response inhibition task.

Authors:  Daniel S Albrecht; David A Kareken; Bradley T Christian; Mario Dzemidzic; Karmen K Yoder
Journal:  Synapse       Date:  2014-02-28       Impact factor: 2.562

4.  Transactional Links Between Teacher-Student Relationships and Adolescent Rule-Breaking Behavior and Behavioral School Engagement: Moderating Role of a Dopaminergic Genetic Profile Score.

Authors:  Steven De Laet; Hilde Colpin; Karla Van Leeuwen; Wim Van den Noortgate; Stephan Claes; Annelies Janssens; Luc Goossens; Karine Verschueren
Journal:  J Youth Adolesc       Date:  2016-03-24

5.  Reciprocal moderation by Toxoplasma gondii seropositivity and blood phenylalanine - tyrosine ratio of their associations with trait aggression.

Authors:  Ashwin Jacob Mathai; Christopher A Lowry; Thomas B Cook; Lisa A Brenner; Lena Brundin; Maureen W Groer; Xiaoqing Peng; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Dietmar Fuchs; Dan Rujescu; Teodor T Postolache
Journal:  Pteridines       Date:  2016-10-21       Impact factor: 0.581

6.  Genotype status of the dopamine-related catechol-O-methyltransferase (COMT) gene corresponds with desirability of "unhealthy" foods.

Authors:  Deanna L Wallace; Esther Aarts; Federico d'Oleire Uquillas; Linh C Dang; Stephanie M Greer; William J Jagust; Mark D'Esposito
Journal:  Appetite       Date:  2015-05-08       Impact factor: 3.868

7.  Modulation of impulsivity and reward sensitivity in intertemporal choice by striatal and midbrain dopamine synthesis in healthy adults.

Authors:  Christopher T Smith; Deanna L Wallace; Linh C Dang; Esther Aarts; William J Jagust; Mark D'Esposito; Charlotte A Boettiger
Journal:  J Neurophysiol       Date:  2015-12-16       Impact factor: 2.714

8.  Tolcapone addition improves Parkinson's disease associated nonmotor symptoms.

Authors:  Thomas Müller
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

Review 9.  Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.

Authors:  Thomas Müller; Paul Foley
Journal:  Clin Pharmacokinet       Date:  2017-03       Impact factor: 6.447

10.  Conditioned task-set competition: Neural mechanisms of emotional interference in depression.

Authors:  Aleks Stolicyn; J Douglas Steele; Peggy Seriès
Journal:  Cogn Affect Behav Neurosci       Date:  2017-04       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.